ASTRAZEN.BOASTRAZEN.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.98% | +25.39% | +35.81% | +37.03% | +38.90% |
| Gross Profit Growth | +22.71% | +104.69% | +150.41% | +28.85% | +26.87% |
| EBITDA Growth | +108.04% | +66.63% | +0.00% | +25.33% | +0.04% |
| Operating Income Growth | +498.41% | +50.53% | +88.93% | +68.08% | -39.65% |
| Net Income Growth | +95.24% | +47.55% | +0.00% | +41.09% | +5.64% |
| EPS Growth | +95.25% | +47.56% | +0.00% | +41.12% | +5.67% |
| EPS Diluted Growth | +95.25% | +47.56% | +0.00% | +41.12% | +5.67% |
| Weighted Average Shares Growth | +0.00% | -0.01% | +0.09% | -0.02% | -0.03% |
| Weighted Average Shares Diluted Growth | +0.00% | -0.01% | +0.09% | -0.02% | -0.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +20.93% | +0.00% | +46.86% | +0.00% |
| Inventory Growth | +0.00% | +140.70% | +0.00% | +103.83% | +0.00% |
| Asset Growth | +0.00% | +40.82% | +0.00% | +30.07% | +0.00% |
| Book Value per Share Growth | +3.72% | +8.22% | +8.11% | +17.64% | +0.00% |
| Debt Growth | +0.00% | +678.43% | +0.00% | +103.21% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -19.80% | -64.65% | -62.07% | -69.74% | +57.61% |